Literature DB >> 28473331

The emerging role of mast cells in liver disease.

Veronica Jarido1, Lindsey Kennedy2,3, Laura Hargrove3, Jennifer Demieville2, Joanne Thomson2, Kristen Stephenson1, Heather Francis4,1,3.   

Abstract

The depth of our knowledge regarding mast cells has widened exponentially in the last 20 years. Once thought to be only important for allergy-mediated events, mast cells are now recognized to be important regulators of a number of pathological processes. The revelation that mast cells can influence organs, tissues, and cells has increased interest in mast cell research during liver disease. The purpose of this review is to refresh the reader's knowledge of the development, type, and location of mast cells and to review recent work that demonstrates the role of hepatic mast cells during diseased states. This review focuses primarily on liver diseases and mast cells during autoimmune disease, hepatitis, fatty liver disease, liver cancer, and aging in the liver. Overall, these studies demonstrate the potential role of mast cells in disease progression.

Entities:  

Keywords:  cholangiopathies; disease; liver; mast cells

Mesh:

Year:  2017        PMID: 28473331      PMCID: PMC5582878          DOI: 10.1152/ajpgi.00333.2016

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  113 in total

1.  Inhibition of mast cell-secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2(-/-) mice.

Authors:  Hannah Jones; Laura Hargrove; Lindsey Kennedy; Fanyin Meng; Allyson Graf-Eaton; Jennifer Owens; Gianfranco Alpini; Christopher Johnson; Francesca Bernuzzi; Jennifer Demieville; Sharon DeMorrow; Pietro Invernizzi; Heather Francis
Journal:  Hepatology       Date:  2016-07-30       Impact factor: 17.425

2.  Mast cells in the rat liver are phenotypically heterogeneous and exhibit features of immaturity.

Authors:  A Chan; M A Cooley; A M Collins
Journal:  Immunol Cell Biol       Date:  2001-02       Impact factor: 5.126

3.  Prognostic significance of interleukin-17 in solid tumors: a meta-analysis.

Authors:  Yunhui Zeng; Qiongwen Zhang; Hong Wang; Minxun Lu; Hongyu Kong; Yingyi Zhang; Huashan Shi
Journal:  Int J Clin Exp Med       Date:  2015-07-15

4.  The action of the mast cell product tryptase on cyclooxygenase-2 (COX2) and subsequent fibroblast proliferation involves activation of the extracellular signal-regulated kinase isoforms 1 and 2 (erk1/2).

Authors:  Mónica B Frungieri; Martin Albrecht; Romi Raemsch; Artur Mayerhofer
Journal:  Cell Signal       Date:  2005-04       Impact factor: 4.315

5.  Bile duct ligation-induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell-deficient KitW-sh mice.

Authors:  Laura Hargrove; Lindsey Kennedy; Jennifer Demieville; Hannah Jones; Fanyin Meng; Sharon DeMorrow; Walker Karstens; Taronish Madeka; John Greene; Heather Francis
Journal:  Hepatology       Date:  2017-04-28       Impact factor: 17.425

6.  Increased portal tract infiltration of mast cells and eosinophils in primary biliary cirrhosis.

Authors:  A Nakamura; K Yamazaki; K Suzuki; S Sato
Journal:  Am J Gastroenterol       Date:  1997-12       Impact factor: 10.864

7.  Mast cell chemotaxis - chemoattractants and signaling pathways.

Authors:  Ivana Halova; Lubica Draberova; Petr Draber
Journal:  Front Immunol       Date:  2012-05-25       Impact factor: 7.561

Review 8.  Mast cell function: a new vision of an old cell.

Authors:  Elaine Zayas Marcelino da Silva; Maria Célia Jamur; Constance Oliver
Journal:  J Histochem Cytochem       Date:  2014-07-25       Impact factor: 2.479

9.  Inhibition of Mast Cell-Derived Histamine Decreases Human Cholangiocarcinoma Growth and Differentiation via c-Kit/Stem Cell Factor-Dependent Signaling.

Authors:  Christopher Johnson; Victoria Huynh; Laura Hargrove; Lindsey Kennedy; Allyson Graf-Eaton; Jennifer Owens; Jerome P Trzeciakowski; Kyle Hodges; Sharon DeMorrow; Yuyan Han; Lucas Wong; Gianfranco Alpini; Heather Francis
Journal:  Am J Pathol       Date:  2015-11-18       Impact factor: 4.307

10.  Mast cells and the liver aging process.

Authors:  Fabio Grizzi; Maurizio Chiriva-Internati; Giuseppe Di Caro; Luigi Laghi; Paul Hermonat; Paolo Mazzola; Diane D Nguyen; Saba Radhi; Jose A Figueroa; Everardo Cobos; Giorgio Annoni
Journal:  Immun Ageing       Date:  2013-03-07       Impact factor: 6.400

View more
  14 in total

Review 1.  Mast cells in liver disease progression: An update on current studies and implications.

Authors:  Linh Pham; Lindsey Kennedy; Leonardo Baiocchi; Vik Meadows; Burcin Ekser; Debjyoti Kundu; Tianhao Zhou; Keisaku Sato; Shannon Glaser; Ludovica Ceci; Gianfranco Alpini; Heather Francis
Journal:  Hepatology       Date:  2021-12-12       Impact factor: 17.298

Review 2.  Interplay between Mast Cells and Regulatory T Cells in Immune-Mediated Cholangiopathies.

Authors:  Natalia M Krajewska; Rémi Fiancette; Ye H Oo
Journal:  Int J Mol Sci       Date:  2022-05-24       Impact factor: 6.208

3.  Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2-/- mice and human cholangiocarcinoma tumorigenesis.

Authors:  Lindsey Kennedy; Laura Hargrove; Jennifer Demieville; Walker Karstens; Hannah Jones; Sharon DeMorrow; Fanyin Meng; Pietro Invernizzi; Francesca Bernuzzi; Gianfranco Alpini; Steven Smith; Austin Akers; Vik Meadows; Heather Francis
Journal:  Hepatology       Date:  2018-06-01       Impact factor: 17.425

Review 4.  Mast Cells in Liver Fibrogenesis.

Authors:  Ralf Weiskirchen; Steffen K Meurer; Christian Liedtke; Michael Huber
Journal:  Cells       Date:  2019-11-13       Impact factor: 6.600

5.  Chemerin-156 is the Active Isoform in Human Hepatic Stellate Cells.

Authors:  Marlen Spirk; Sebastian Zimny; Maximilian Neumann; Nichole McMullen; Christopher J Sinal; Christa Buechler
Journal:  Int J Mol Sci       Date:  2020-10-13       Impact factor: 5.923

6.  Plasma and stool metabolomics to identify microbiota derived-biomarkers of metabolic dysfunction-associated fatty liver disease: effect of PNPLA3 genotype.

Authors:  Flavia Noelia Mazzini; Frank Cook; John Gounarides; Sebastián Marciano; Leila Haddad; Ana Jesica Tamaroff; Paola Casciato; Adrián Narvaez; María Florencia Mascardi; Margarita Anders; Federico Orozco; Nicolás Quiróz; Marcelo Risk; Susana Gutt; Adrián Gadano; Celia Méndez García; Martin L Marro; Alberto Penas-Steinhardt; Julieta Trinks
Journal:  Metabolomics       Date:  2021-06-16       Impact factor: 4.290

7.  Effects of fake and original perfumes on the presence, numbers, and distribution of mast cells in selected tissues in rats.

Authors:  Wael M Hananeh; Fatima Al Ghbari; Raida Al Rukibat; Mohammad Al Zghoul; Zuhair Bani Ismail
Journal:  Open Vet J       Date:  2021-06-06

Review 8.  Intercellular Communication between Hepatic Cells in Liver Diseases.

Authors:  Keisaku Sato; Lindsey Kennedy; Suthat Liangpunsakul; Praveen Kusumanchi; Zhihong Yang; Fanyin Meng; Shannon Glaser; Heather Francis; Gianfranco Alpini
Journal:  Int J Mol Sci       Date:  2019-05-02       Impact factor: 5.923

Review 9.  HLA-G Expressing Immune Cells in Immune Mediated Diseases.

Authors:  P Contini; Giuseppe Murdaca; Francesco Puppo; Simone Negrini
Journal:  Front Immunol       Date:  2020-08-28       Impact factor: 7.561

10.  Tryptophan Metabolism via the Kynurenine Pathway: Implications for Graft Optimization during Machine Perfusion.

Authors:  Anna Zhang; Cailah Carroll; Siavash Raigani; Negin Karimian; Viola Huang; Sonal Nagpal; Irene Beijert; Robert J Porte; Martin Yarmush; Korkut Uygun; Heidi Yeh
Journal:  J Clin Med       Date:  2020-06-15       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.